Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-14 Sale |
2023-04-14 4:19 pm |
Jasper Therapeutics Inc. | JSPR | French Anna Louise Director |
7,000 | $1.48 | $10,360 | 23,750 (Direct) |
View |
| 2023-04-13 Sale |
2023-04-14 4:19 pm |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director |
9,075 | $1.4903 | $13,524 | 21,175 (Direct) |
View |
| 2023-04-13 Sale |
2023-04-14 4:14 pm |
Jasper Therapeutics Inc. | JSPR | Lis William Director |
8,500 | $1.44 | $12,240 | 61,486 (Direct) |
View |
| 2023-01-27 Purchase |
2023-04-11 7:55 pm |
Jasper Therapeutics Inc. | JSPR | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK RIESCHEL GARY E 10% Owner |
2,666,666 | $1.5 | $3,999,999 | 8,519,648 (Direct) |
View |
| 2023-01-27 Purchase |
2023-01-31 5:24 pm |
Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Abingworth LLP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
3,133,333 | $1.5 | $4,700,000 | 8,761,891 (Indirect) |
View |
| 2023-01-25 Sale |
2023-01-26 5:49 pm |
Jasper Therapeutics Inc. | JSPR | ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner |
75,000 | $1.89 | $141,750 | 4,549,606 (Indirect) |
View |
| 2022-06-24 Sale |
2022-06-28 4:01 pm |
Jasper Therapeutics Inc. | JSPR | Lis William Director |
49,486 | $2.0498 | $101,434 | 40,486 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-08 6:44 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | Kapoor Vishal Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:44 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:43 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:43 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:42 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | Nolet Chris Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:42 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | Lis William Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-08 6:41 pm |
2024-06-07 2033-06-07 |
Jasper Therapeutics Inc. | JSPR | French Anna Louise Director |
47,000 | $0 | 47,000 (Direct) |
View |
| 2023-04-12 Tax Withholding |
2023-04-14 4:17 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO and Director |
87,531 | $1.46 | 418,719 (Direct) |
View |
| 2023-04-12 Tax Withholding |
2023-04-14 4:16 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks |
37,126 | $1.46 | 287,223 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-20 6:00 pm |
N/A 2033-03-17 |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-20 5:59 pm |
N/A 2033-03-17 |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO and Director |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership(A) |
2023-02-27 8:35 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Kapoor Vishal Director |
0 | $0 | 43,750 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-17 08:30 am |
N/A 2033-02-16 |
Jasper Therapeutics Inc. | JSPR | Kapoor Vishal Director |
109,383 | $0 | 109,383 (Direct) |
View |
Ownership |
2023-02-03 4:35 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Velan Capital Investment Management LP Velan Capital Master Fund LP Avego Healthcare Capital L.P. Velan Capital Holdings LLC Avego Healthcare Capital Holdings LLC Avego Management LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam 10% Owner |
0 | $0 | 11,219,036 (Indirect) |
View |
| 2023-02-02 Option Award |
2023-02-03 4:13 pm |
N/A 2033-02-02 |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO & Director |
1,093,831 | $0 | 1,093,831 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:08 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO and Director |
506,250 | $0 | 506,250 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:07 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director |
24,500 | $0 | 24,500 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:05 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director |
30,250 | $0 | 30,250 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:03 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director |
29,500 | $0 | 1,159,012 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:02 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks |
214,722 | $0 | 324,349 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 8:00 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Nolet Chris Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 7:58 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Lis William Director |
29,500 | $0 | 69,986 (Direct) |
View |
| 2022-10-12 Option Award |
2022-10-13 7:56 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | French Anna Louise Director |
30,750 | $0 | 30,750 (Direct) |
View |
Ownership |
2022-08-11 4:57 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
0 | $0 | 5,706,603 (Indirect) |
View |
| 2022-04-07 Option Award |
2022-04-08 4:01 pm |
N/A 2032-04-07 |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh See Remarks |
48,441 | $0 | 48,441 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:06 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | MARTELL RON President, CEO and Director |
1,704,328 | $0 | 1,704,328 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:05 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Klein Lawrence Otto Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:04 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | EMSTER KURT VON Director 10% Owner |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:04 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Heller Kevin N. See Remarks |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:03 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Shizuru Judith Anne Director |
78,045 | $0 | 78,045 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:02 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Mahal Jeetinder Singh COO,CFO and CS |
94,772 | $0 | 94,772 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-23 6:01 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Nolet Chris Director |
78,045 | $0 | 78,045 (Direct) |
View |